UPDATE: Learn more about noncompliance and withdrawal of applications by reading our Frequently Asked Questions.

We frequently come across compliance issues when reviewing NIGMS T32, T34, and K12 institutional training grant applications. We’re providing information to help applicants avoid the consequences of not following the funding opportunity announcement (FOA) instructions, which could result in the withdrawal of applications without review:

We’re pleased to share that the NIGMS National and Regional Resource Program (R24) funding opportunity announcement (FOA) has been reissued (PAR-22-065). This program began in 2019 to provide access to state-of-the-art facilities, equipment, technologies, research tools, and software that aren’t generally available to a large number of researchers. To date, the program has established 12 resources that serve the scientific community on a national or multistate regional basis and offer a breadth of technologies. Below, we highlight just a few. We encourage you to explore all of the resources made available through this program and to learn more about the new FOA on our National and Regional Resources webpage.  

Are you preparing a grant application for the Graduate Research Training Initiative for Student Enhancement (G-RISE) or the Initiative for Maximizing Student Development (IMSD) predoctoral institutional research training program? If so, please join our informational webinar to learn about the programs and application components. You’ll also have the opportunity to ask us questions:

Friday, December 3, 1:30-3:00 p.m. ET

We’re hosting a webinar for Postbaccalaureate Research Education Program (PREP) (PAR-20-066) applicants:

Tuesday, November 30, 1:00-2:30 p.m. ET

We’re pleased to announce that the IDeA Regional Entrepreneurship Development (I-RED) Program (STTR) funding announcement (RFA-GM-22-001) has been issued. The purpose of this initiative is to provide support for eligible small business concerns in each of the IDeA regions (Central, Northeast, Southeast, and West) to develop educational products promoting biomedical entrepreneurship in IDeA-eligible states. These products are expected to help academic institutions in these states translate scientific discoveries and technologies from research laboratories into commercial products.

The application due date is January 5, 2022.

If you’re planning to apply for a Phase 1, 2, or 3 Centers of Biomedical Research Excellence (COBRE) grant, it’s important that you attend our upcoming webinar:

Wednesday, October 27, 3:00-4:30 p.m. ET

During the webinar, we’ll present an overview of the COBRE program’s objectives, eligibility and reporting requirements, and other key aspects of the funding opportunity announcements. We’ll also answer any questions that you have.

We’re pleased to announce that we’ve published two notices of special interest (NOSI) calling for applications to PAR-19-313, Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 Clinical Trial Optional), that focus on research on women’s health (NOT-GM-21-056) and data sciences (NOT-GM-21-062).

These NOSIs highlight the Office of Research on Women's Health's interest in supporting a meritorious application on women's health, and the Office of Data Science Strategy’s interest in supporting a meritorious application on data science relevant to biomedical research. Applications for these NOSIs must be submitted in response to and meet all eligibility criteria of PAR-19-313.

UPDATE: The video and slides [PDF] from the webinar are now available.

We’re pleased to share that the Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) funding opportunity announcements (FOAs) have been reissued. MOSAIC, a trans-NIH initiative that NIGMS oversees, has two components: a postdoctoral career transition award (K99/R00), and a cohort-based mentoring and career development program that supports the scholars (UE5 research education cooperative agreement).

UPDATE: The video from the Interventions webinar is now available.

NIGMS has reissued its funding opportunity announcement (FOA) for Research on Interventions that Promote the Careers of Individuals in the Biomedical Research Enterprise (R01) (PAR-21-269). In line with a key mission area of the Institute—ensuring the vitality and continued productivity of the research enterprise—the FOA encourages studies on interventions aimed to enhance research-oriented individuals’ interest, motivation, persistence, and preparedness for careers in the biomedical research workforce. Potential intervention focus areas include, but are not limited to, networking and mentoring, institutional climate, harassment, and structural racism and discrimination.

The new FOA no longer includes research designed solely to inform interventions; applicants must also conduct and test an intervention. Proposals must test the effectiveness of an intervention using robust experimental designs, such as randomized control trial approaches, case controls, matched pair design, or other designs appropriate to perform rigorous research on effective interventions aiming to increase success in the biomedical research workforce.

NIGMS staff members always closely examine each principal investigator’s (PI’s) other research support when making funding recommendations and awards. In addition, the Institute has several policies to ensure a diversified portfolio of grants. At the May 20, 2021, NAGMS Advisory Council meeting, councilors approved our updated NIGMS guidelines for funding investigators with substantial other research support. Informally, this was known as our $750K policy. What’s the policy, and why are we changing it now?